Adare Pharma Solutions
7722 Dungan Rd
Philadelphia, PA 19111

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. With a proven history in drug delivery, Adare has developed and manufactured more than 65 products sold by customers worldwide.


Adare provides end-to-end CDMO services, from clinical trial materials and product development to commercial manufacturing and packaging. We can develop and manufacture oral dose products from start to finish, and we can tech transfer pre-established projects into our facilities.

Adare’s industry-leading experts possess unparalleled experience in the development of unique dosage forms that provide taste masking, customized release, and patient-centric solutions. Our technology platforms overcome complex formulation challenges to improve the lives of all patients, with expertise in pediatric, geriatric, and dysphagic requirements.

Adare operates seven facilities in the US and Europe, staffed by nearly 800 employees. With our global manufacturing network, Adare is capable of serving markets throughout the world. From our state-of-the-art facilities in the US and Europe, we can provide development-scale through commercial-scale production, with a continuum of highly specialized manufacturing services and capabilities to meet any customer’s oral solid dose needs.


Standard Offerings

  • Granulation & Mixing
  • Roller Compaction
  • Fluid bed processing & drying
    -Top Spray
  • Hot Melt Extrusion
  • Pan coating
  • Blending (Bin and Static)
  • Tableting
  • Multi-layer tablets
  • Capsule filling
  • Oven drying
  • Small-scale GMP manufacturing
  • Tech transfer services
  • Warehousing & distribution

Specialized Offerings

  • Microencapsulation of solids and liquids
  • Orally disintegrating tablets (ODT)
  • Dry syrup/suspensions
  • MMTSTM Minitabs
  • DEA Controlled substances:
    -Manufacturing: Schedules II, 2N, III, 3N, IV, V, and L1
    -Analytical Labs: Schedules I–V
  • High Potency: 1 mcg/m3 and above
  • Fixed-dose combination manufacturing
  • Liquid filling in hard-shell capsules with banding
  • Solvent granulation and coating processes
  • Food sprinkle dosage forms

Packaging Capabilities

  • Dedicated 175k sq. ft. packaging & warehousing facility
  • High-speed bottle packaging
  • Blister packaging
  • Packaging of DEA schedules II, 2N, III, 3N, IV, L1
  • Serialization & aggregation